Ireland
--:--IST
Priya Life Science Sponsor trial record
Sponsor · clinical trials

Johnson & Johnson Medical (Shanghai) clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our China register with Johnson & Johnson Medical (Shanghai) as lead sponsor. Synced 5 Nov 2026
3Current trials
3Recruiting now
0Drugs in these trials
1Trial register
At a glance

Johnson & Johnson Medical (Shanghai) is the lead sponsor of 3 current clinical trials in our China register. 3 are recruiting patients now. All registered phases are Observational. The most-studied condition is Atrial Fibrillation.

Company profiles on this site (news, sites, medicines, approvals): Johnson & Johnson Ireland (IE) →Johnson & Johnson (US) →

ClinicalTrials.gov trials by status

  • Recruiting3100%

Trials by phase

  • Observational3100%
01

Clinical trials sponsored by Johnson & Johnson Medical (Shanghai)

3 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
A Study of Varipulse Catheter in Participants With Paroxysmal Atrial Fibrillation Under Optimized Sedation
NCT07511166 · ClinicalTrials.gov ↗ · Atrial Fibrillation
Observational Recruiting 2026-10 China
A Study of Choydar Flow-Directed Mesh Stent in the Treatment of Unruptured Intracranial Aneurysms
NCT07228312 · ClinicalTrials.gov ↗ · Intracranial Aneurysm
Observational Recruiting 2026-01 China
The Study is an Observational Post-market Follow-up Program to Evaluate Long Term (5 Years) Safety of Mentor Breast Implants in Chinese Population
NCT06510205 · ClinicalTrials.gov ↗ · Breast Augmentation, Mammaplasty
Observational Recruiting 2024-07 China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in Johnson & Johnson Medical (Shanghai) trials

4 conditions
Atrial Fibrillation1Intracranial Aneurysm1Breast Augmentation1Mammaplasty1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in China33

A trial with sites in more than one country appears in each of those registers.

04

Other sponsors in Atrial Fibrillation

SponsorTrials
Yonsei University12
Ottawa Heart Institute Research Corporation8
Biosense Webster7
Boston Scientific Corporation6
Volta Medical5
China National Center for Cardiovascular Diseases5
Population Health Research Institute4
Medtronic Cardiac Ablation Solutions4
Insel Gruppe AG, University Hospital Bern4
Universitätsklinikum Hamburg-Eppendorf3

Sponsors with the most current trials registered for this condition.

05

Questions about Johnson & Johnson Medical (Shanghai) trials

How many clinical trials does Johnson & Johnson Medical (Shanghai) sponsor?

Johnson & Johnson Medical (Shanghai) is the lead sponsor of 3 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 5 November 2026. Completed and withdrawn studies are not counted.

Are Johnson & Johnson Medical (Shanghai) trials recruiting?

Yes. 3 of its 3 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 5 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.